SUNRAY-01, a Pivotal, Global Study of Olomorasib (LY3537982) in Combination with Pembrolizumab with or Without Chemotherapy for 1L Treatment in KRAS G12C-mutant Advanced NSCLC.Marcelo Vailati Negrao,Kathryn C. Arbour,Timothy F. Burns,Federico Cappuzzo, Anne-Marie C. Dingemans,Nicolas Girard,Bjorn Henning Gronberg,Maximilian Hochmair,Ticiana Leal,Colin R. Lindsay,Shun Lu,Makoto Nishio, Luis G. Paz-Ares,Martin Reck,Joshua K. Sabari, Alexander I. Spira,William Nassib William, Aaron Chen,Carla M. Visseren Grul,Solange PetersJournal of Clinical Oncology(2024)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要